Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 78 clinical trials
Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

Compelling evidences support the safety of direct oral anticoagulants (DOAC) compared to Vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation. The 2018 EHRA/ESC

edoxaban
anticoagulation therapy
vitamin k
anticoagulant therapy
anticoagulants
  • 6 views
  • 26 Jan, 2021
  • 1 location
PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and Prognostic Value of Hepatic Tumors in Infants

efficiency of Protein Induced by Vitamin K Absence or antagonist-II(PIVKA-II) combining with alpha-fetoprotein in hepatic tumor of infant. This study is a multicenter study joined by several hospitals in

liver tumor
tumor markers
pivka-ii
  • 0 views
  • 24 Jan, 2021
  • 1 location
Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Among patients who are receiving long-term anticoagulant therapy, whether with a direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA), approximately 3-5% who require treatment

secondary prevention
edoxaban
thromboembolism
vitamin k
anticoagulant therapy
  • 5 views
  • 23 Jan, 2021
  • 3 locations
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Antithrombotics with antiplatelet agents, vitamin K antagonist (VKA), heparin and related substances, and new oral anticoagulants are prescribed for arterial diseases, especially in secondary

  • 0 views
  • 21 Jan, 2021
Italian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS)

standard therapy (direct vitamin K antagonists, VKA). In the specific case of the Rivaroxaban, several experimental trials have shown how the uninterrupted administration of the drug before the

arrhythmia
vitamin k
anticoagulant therapy
anticoagulants
catheter ablation
  • 0 views
  • 25 Jan, 2021
  • 1 location
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

The purpose of this study is to evaluate the safety and efficacy of apixaban for the prevention of thromboembolism in adult patients with congenital heart disease (CHD) and non-valvular atrial arrhythmias (AA)

arrhythmia
apixaban
thromboembolism
  • 2 views
  • 03 Feb, 2021
  • 8 locations
Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

The primary objective is to assess the safety and efficacy of switching from direct oral anticoagulants to low molecular weight heparin in cancer patients during antineoplastic therapy

edoxaban
cancer
primary cancer
embolism
anticoagulants
  • 20 views
  • 25 Jan, 2021
  • 2 locations
Bone Density and Vascular Calcifications Evolution After Renal Transplant

The investigators project is based on: Assessment of bone architecture by high resolution peripheral scanner (HRpQCT) and bone densitometry (DEXA); The non-invasive detection of vascular calcifications (by abdominal CT scanner) and bone abnormalities associated with kidney transplantation, as well as the analysis of their evolution over time; Longitudinal evaluation of …

  • 0 views
  • 28 Jan, 2021
  • 1 location